|
 |
 |
 |
 |
|
A 30 year old woman with gradual vision loss OU
Digital Journal of Ophthalmology 2005 Volume 11, Number 15 August 15, 2005
|
Printer Friendly
|
|
|
|
References | 1. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998; 105:1801-15.
2. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1989;107:237-43.
3. ETDRS Treatment Group. Early Photocoagulation for Diabetic Retinopathy, ETDRS Report Number 9. Ophthalmology 1991;98:766-85.
4. Melberg NS, Grand MG, Rup D. The impact of acute lymphocytic leukemia on diabetic retinopathy. J Pediatr Hematol Oncol. 1995;17:81-84.
5. Chaum, E. (2000) Purtscher’s Retinopathy, In eMedicine, Ophthalmology. www.eMedicine.com.
6. Ernst E, Hammerschmidt DE, Bagge U, et al. Leukocytes and the risk of ischemic diseases. JAMA. 1987; 257:2318-24.
7. Phair JP, Anderson RE, Maniki H. The central nervous system in leukemia. Ann Intern Med. 1964;61:863.
8. Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood. 2000; 96: 2240-5.
9. Sillaber C, Mayerhofer M, Aichberger KJ, et al. Expression of angiogenic factors in chronic myeloid leukaemia: role of the bcr/abl oncogene, biochemical mechanisms, and potential clinical implications. Eur J Clin Invest. 2004; 34 Suppl 2:2-11.
| |
|
 |
 |
 |

|
|